Amyloid-targeting Alzheimer's drugs give us hope – but how will they benefit UK patients?
Amyloid-targeting drugs donanemab and lecanemab show promise for slowing the rate of cognitive decline
Source: telegraph.co.uk
Fast, Ad-Free News Updates
Stay updated with breaking news from However Aziz. Real-time updates on events, politics, business and more.